• Tunable Human Intestinal Organoids: Study Insights

  2026-08-28

  A 2025 Nature Communications study establishes a human small intestinal organoid system that maintains strong proliferation while expanding cellular diversity under a single culture condition. Its central innovation is to increase stem-cell competence first, then use reversible or directional pathway modulation to tune secretory, enterocyte, and other intestinal fates without recreating artificial spatial gradients.

• Gamithromycin: From Lung PK to Translational Strategy

  2026-08-28

  Gamithromycin, also known as ML-1709460, illustrates why respiratory anti-infective research should connect ribosomal mechanism, pulmonary distribution, intracellular exposure, and AUC24h/MIC rather than rely on plasma concentration alone. This evidence-led perspective translates foal pharmacokinetic findings into practical strategies for veterinary respiratory models while defining the limits of cross-species extrapolation.

• Carbapenemase Gene Dynamics in CREC, 2022–2024

  2026-08-27

  A 2025 BMC Microbiology study mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong, combining gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and ERIC-PCR typing. Its findings identify plasmid-associated blaNDM-1 as a major transmission concern and show why resistance phenotyping should be interpreted alongside molecular surveillance.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-08-27

  The reference study introduces enveloped virus-mimicking particles (EVMPs), a bottom-up platform that combines engineered self-assembling peptides with tunable phospholipid envelopes to deliver mRNA beyond the liver. Optimized particles targeted lung and spleen tissues, reached defined lung cell populations, and suppressed metastatic lung tumors when loaded with IL-12 mRNA, while retaining a low-immunogenicity profile suitable for repeated administration.

• DAF-2 diacetate: Reliable NO Assay Workflows

  2026-08-26

  Learn how DAF-2 diacetate, including SKU C4210, can strengthen live-cell nitric oxide imaging and complementary viability or cytotoxicity workflows. This scenario-driven guide covers probe chemistry, assay compatibility, optimization, interpretation, and practical product-selection criteria.

• ddhCTP: Designing Mechanism-Resolved Antiviral Assays

  2026-08-26

  Explore how ddhCTP, or 3ʹ-deoxy-3′,4′-didehydro-CTP, can be evaluated as a mechanism-defined inhibitor of viral RNA synthesis. This guide connects flavivirus assays with new evidence separating ddhCTP-dependent chain termination from viperin-mediated disruption of coronavirus replication complexes.

• 4-Ethylphenyl Sulfate at the Gut–Brain Axis

  2026-08-25

  A translational framework for using 4-ethylphenyl sulfate to connect microbiota-derived chemistry with renal dysfunction, biomaterial interfaces, and neurobehavioral phenotypes.

• Cy7 NHS Ester: Practical Near-Infrared Labeling

  2026-08-25

  Cy7 NHS ester (SKU A8109) is a water-soluble protein labeling dye for attaching near-infrared fluorescence to accessible amino groups on proteins, peptides, and related biomolecules. It is well suited to aqueous labeling and near-infrared fluorescent imaging, but freshly prepared solutions should be used promptly and application-specific performance must be validated because no directly matched paper evidence is supplied here.

• Canagliflozin Reshapes Mitochondria in Diabetic Kidneys

  2026-08-24

  The reference study shows that Canagliflozin improves mitochondrial architecture and bioenergetics in proximal tubular cells from hypertensive–diabetic mice, with stronger functional effects in males than females. These findings extend the interpretation of SGLT2 inhibition beyond glucose lowering and identify mitochondrial remodeling as a potential component of renal protection.

• Anagliptin Assay Design for Vascular Research

  2026-08-24

  Anagliptin (SK-0403) is more than a DPP-4 inhibitor in vascular experiments. This guide shows how to separate incretin pharmacology from direct smooth-muscle effects and design mechanistically informative rabbit-aorta assays.

• From S-Phase Signal to Vascular Mechanism

  2026-08-23

  A translational framework for using EdU-based flow cytometry to connect DNA synthesis with endothelial–smooth muscle crosstalk, hypoxia pulmonary hypertension, genotoxicity testing, and pharmacodynamic decision-making.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-08-22

  The reference study identifies circulating moesin (MSN) as a severity-associated biomarker of endothelial injury in sepsis and links its elevation to Rock1/MLC and NF-κB signaling. By combining patient measurements, mouse models, and endothelial-cell experiments, the work connects clinical association with a plausible mechanism of vascular barrier disruption.

• Exo1 in Exocytosis Assay Design

  2026-08-22

  Exo1 enables acute, mechanistically distinct membrane trafficking inhibition for Golgi–ER transport, ARF1 biology, and exocytosis assays. Used with appropriate controls, it can also help separate secretion-dependent effects from tumor extracellular vesicle behavior without being misrepresented as a direct or clinically validated metastasis therapy.

• OSMI-1: O-GlcNAc Transferase Inhibitor Guide

  2026-08-21

  OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor that reduces protein O-GlcNAcylation through OGT inhibition. Its reported biochemical potency, cellular viability effect, zebrafish acute-toxicity benchmarks, and formulation limits support controlled mechanistic research rather than direct therapeutic interpretation.

• Cimetidine in BBB and H2R Research Workflows

  2026-08-20

  Cimetidine supports a practical two-track workflow: mechanistic H2 receptor studies in gastrointestinal cancer models and controlled transport testing in surrogate blood-brain barrier assays. Its documented solubility and distinct pharmacological profile make it useful for assay development, provided permeability, recovery, and receptor effects are interpreted separately.

8034 records 1/536 page Next 12345 下5页 Last page